Full Text of SR0454 100th General Assembly
SR0454 100TH GENERAL ASSEMBLY |
| | SR0454 | | LRB100 12489 MST 25431 r |
|
| 1 | | SENATE RESOLUTION
| 2 | | WHEREAS, Pediatric acute-onset neuropsychiatric syndrome | 3 | | (PANS) and pediatric autoimmune neuropsychiatric disorder | 4 | | associated with streptococcal infection (PANDAS) create the | 5 | | sudden onset of obsessive-compulsive disorder in children, | 6 | | causing previously healthy and emotionally adjusted children | 7 | | to experience severe anxiety and emotional disturbances; and
| 8 | | WHEREAS, Children with PANS and PANDAS tend to manifest | 9 | | some of the following symptoms: tics or other abnormal | 10 | | movements, severe separation anxiety, generalized anxiety, | 11 | | irritability, aggression, personality changes, ADHD, marked | 12 | | deterioration in learning and school performance, and | 13 | | developmental regression, including deterioration in | 14 | | handwriting; and
| 15 | | WHEREAS, PANS is broader than PANDAS as it includes not | 16 | | only disorders associated with a preceding infection, such as | 17 | | Mycoplasma Pneumoniae, Mono, Lyme, viruses, and more, but also | 18 | | acute onset non-infectious triggers, such as environmental | 19 | | factors and metabolic dysfunction; treatment plans similar to | 20 | | those for PANDAS should be attempted; and
| 21 | | WHEREAS, Children with PANS and PANDAS may experience | 22 | | moderate to dramatic improvement with antibiotics, steroids, |
| | | SR0454 | - 2 - | LRB100 12489 MST 25431 r |
|
| 1 | | intravenous immunoglobulin treatment, or plasmapheresis; and | 2 | | WHEREAS, Researchers at the National Institute of Mental | 3 | | Health, along with 13 Centers for Excellence throughout the | 4 | | country, are currently engaged in extensive research to | 5 | | elucidate the causes and develop further effective treatment | 6 | | options for PANS and PANDAS; and
| 7 | | WHEREAS, Researchers at Moleculera Labs at the University | 8 | | of Oklahoma have developed PANS and PANDAS blood testing | 9 | | procedures; and | 10 | | WHEREAS, The expert members of the physicians specialty | 11 | | society, the PANDAS Physicians Network, have developed and | 12 | | published standard treatment methods; and | 13 | | WHEREAS, The organization PANDAS/PANS Advocacy and Support | 14 | | strives to build public awareness, educate medical providers | 15 | | about the disorder and treatments for same, build support for | 16 | | legislation involving the disorder, and provide support and | 17 | | resources for families affected by PANDAS/PANS, in accordance | 18 | | with section 501(c)(3); and
| 19 | | WHEREAS, The actual number of children suffering from PANS | 20 | | and PANDAS has been estimated to be approximately one out of | 21 | | every 200 children in the United States; and
|
| | | SR0454 | - 3 - | LRB100 12489 MST 25431 r |
|
| 1 | | WHEREAS, It is imperative that there be greater public | 2 | | awareness of this serious health issue; therefore, be it
| 3 | | RESOLVED, BY THE SENATE OF THE ONE HUNDREDTH GENERAL | 4 | | ASSEMBLY OF THE STATE OF ILLINOIS, that we designate the date | 5 | | of October 9 of 2017 and 2018 as PANS and PANDAS Awareness Day | 6 | | in the State of Illinois; and be it further
| 7 | | RESOLVED, That a suitable copy of this resolution be | 8 | | presented to Wendy Nawara, President of PANDAS/PANS Advocacy | 9 | | and Support of Illinois.
|
|